H.R. 3 - Lower Drug Costs Now Act
GPTKB entity
Properties (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
legislation
|
| gptkbp:aimsTo |
reduce prescription drug costs
billions in healthcare costs |
| gptkbp:associated_with |
increase healthcare access
healthcare_reform |
| gptkbp:challenges |
Republican_lawmakers
|
| gptkbp:controversy |
gptkb:Congress
|
| gptkbp:crosses |
gptkb:the_House_of_Representatives
|
| gptkbp:designedBy |
allow_Medicare_to_negotiate_drug_prices
|
| gptkbp:has_a_focus_on |
healthcare_activists
|
| gptkbp:has_implications_for |
healthcare_providers
Medicaid_and_private_insurance |
| https://www.w3.org/2000/01/rdf-schema#label |
H.R. 3 - Lower Drug Costs Now Act
|
| gptkbp:includes |
transparency in drug pricing
|
| gptkbp:initiatives |
reform the pharmaceutical industry
|
| gptkbp:introduced |
gptkb:the_House_of_Representatives
2019 |
| gptkbp:is_a_key_component_of |
the_Democratic_platform
|
| gptkbp:is_a_model_for |
future drug pricing legislation
|
| gptkbp:is_a_subject_of |
public hearings
drug affordability healthcare_costs |
| gptkbp:is_designed_to |
patient outcomes
health disparities consumer protections increase access to affordable medications |
| gptkbp:is_essential_for |
universal healthcare access
progressive_Democrats healthcare_reform. |
| gptkbp:is_expected_to |
millions of Americans
legal challenges future healthcare legislation state-level healthcare policies |
| gptkbp:is_linked_to |
gptkb:the_Affordable_Care_Act
healthcare_equity |
| gptkbp:is_part_of |
government intervention in drug pricing
lower overall healthcare spending other healthcare reforms Biden_administration's_healthcare_strategy the_Democratic_agenda_on_healthcare |
| gptkbp:is_studied_in |
policy experts
|
| gptkbp:is_supported_by |
various healthcare advocacy groups
|
| gptkbp:landmark |
healthcare_legislation
|
| gptkbp:landscape |
pharmaceutical pricing
|
| gptkbp:mandates |
capping_out-of-pocket_costs_for_Medicare_beneficiaries
|
| gptkbp:opposedBy |
pharmaceutical industry lobbyists
|
| gptkbp:requires |
drug manufacturers to provide rebates
|
| gptkbp:sponsor |
Representative_Frank_Pallone
|
| gptkbp:targets |
high-cost prescription drugs
|
| gptkbp:was_a_response_to |
lower drug prices
rising drug prices |